Voyager Therapeutics (VYGR) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 2.25% |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 7.34% |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 18.35% |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -12.33% |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | -3.86% |
| 10 | Voyager Therapeutics | 195.27 Mn | 78.93 Mn | - | -19.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.58% |
| Mar 31, 2026 | -12.28% |
| Dec 31, 2025 | -8.23% |
| Sep 30, 2025 | -12.56% |
| Jun 30, 2025 | -14.43% |
| Mar 31, 2025 | -19.86% |
| Dec 31, 2024 | -13.22% |
| Sep 30, 2024 | -11.15% |
| Jun 30, 2024 | -5.64% |
| Mar 31, 2024 | 1.42% |
| Dec 31, 2023 | -7.63% |
| Sep 30, 2023 | -5.38% |
| Jun 30, 2023 | -9.61% |
| Mar 31, 2023 | -11.54% |
| Dec 31, 2022 | -18.54% |
| Sep 30, 2022 | -21.36% |
| Jun 30, 2022 | -19.49% |
| Mar 31, 2022 | -20.99% |
| Dec 31, 2021 | -13.82% |
| Sep 30, 2021 | -0.95% |